CDMRP Tuberous Sclerosis Complex Research Program: Clinical Translational Research Award

The Clinical Translational Research Award supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis, or treatment of TSC.

Projects supported by this award mechanism may include, but not limited to:

• Studies moving from preclinical to clinical research and/or the reverse.
• Studies advancing clinical trial readiness through development of biomarkers, clinical endpoints and validation of pharmacokinetics/pharmacodynamics.
• Pilot clinical trials.
• New studies improving clinical care of TSC encompassing the analysis of existing real-world clinical practice data to develop/improve guidelines for better outcomes in defined areas relevant to the FY26 TSCRP CTRA Focus Areas.

Projects that are exploratory and/or strictly animal research will not be considered for funding.

It is expected that 2 awards will be granted. 

Funding: $1,600,000 total ($300,000 addition for partnering PI) 
Duration: 3 years

Research Authority due date: 16.7.26

Pre application (required) due date: 23.7.26

Full application due date: 6.8.26